Food/Recall·openFDA/food

Wawa Beverage Company — Class I: Wawa Diet Lemonade Pint (16oz), Plastic bottle

HighPublished Jun 3, 2026· AI-analyzed Jun 8, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

The Wawa Beverage Company has initiated a Class I recall for its Wawa Diet Lemonade Pint (16oz) in plastic bottles due to an undeclared milk allergen. The recall is currently classified as ongoing by the FDA.

Who it affects

Wawa Beverage Company, beverage manufacturing facilities, quality assurance departments, and supply chain managers involved in the distribution of bottled juices and lemonades.

Why it matters

A Class I recall is the most serious designation, indicating that the product may cause serious adverse health consequences or death. In this case, the presence of undeclared milk in a lemonade product suggests a significant failure in allergen control programs, cross-contamination prevention, or labeling accuracy. For regulatory teams, this highlights the critical requirement to verify that non-dairy product lines are strictly segregated from dairy ingredients or that labels undergo rigorous verification against current formulations.

Practical takeaway

Conduct an immediate audit of labeling verification procedures for bottled beverages and perform a root cause analysis to determine how a dairy allergen was introduced or failed to be declared in a citrus-based product. Operations should verify that current inventory matches the product description and remains isolated during the ongoing recall process.

FDA source material

Class I. Reason: Undeclared Milk Allergen,. Product: Wawa Diet Lemonade Pint (16oz), Plastic bottle. Firm: Wawa Beverage Company (Media PA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.